MedTrace Logo

Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty

NCT02185924 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-07-10

No results posted yet for this study

Summary

Combination of continuous femoral block with parEcoxib vs placebo. Investigation of morphine consumption, opioid sparing effects, VAS pain scores, haemodynamics, Anxierty scores, transfusion requirements , Range of motion and rehabilitation parameters between two groups

Conditions

  • POSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFB

Interventions

DRUG

Parecoxib

DRUG

CONTINUOUS FEMORAL BLOCK WITH ROPIVACAINE 0,2%

DRUG

N/S 0.9%

Sponsors & Collaborators

  • Asklepieion Voulas General Hospital

    lead OTHER_GOV

Principal Investigators

  • DESPOINA SARRIDOU, SENIOR REGISTRAR · SENIOR CLINICAL FELLOW THE ROYAL BROMPTON AND HAREFIELD TRUST, SENIOR REGISTRAR IN ANAESTHESIA ASKLEPEION VOULAS

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-09-30
Completion
2014-02-28

Countries

  • Greece

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185924 on ClinicalTrials.gov